Lutz Giebel - Info zur Person mit Bilder, News & Links

	Großderschau

	Director Architekt CEO Sciences Managing Partner Office Robert Ventures David Michael Ross San Francisco Raises Health CyThera BIO

News

(1 - 4 von 19

–alle anzeigen

)

Labs Say They Can Supply Enough Stem Cells | Fox News

www.foxnews.com

Sixty-four human embryonic stem cell colonies that officials say can be used for federally funded studies are enough to keep scientists busy for years doing...

SV Life Sciences schließt Finanzierungsrunde für seinen vierten...

www.finanznachrichten.de

Das Investitionsteam von SLVS besteht aus den geschäftsführenden Partnern James Garvey, Kate Bingham, Lutz Giebel, Eugene Hill, David ...

Lutz Giebel is at the nucleus of nations debate on embryonic stem...

www.remedyspot.com

Lutz Giebel is at the nucleus of nations debate on embryonic stem cells for research - posted in Health, Medicine and Natural Healing 02: My ...

Neurotech Inc. schliesst private Finanzierungsrunde mit 35 Mio. USD

www.finanznachrichten.de

... Dr. William J. Link von Versant Ventures und Dr. Lutz Giebel von SV Life Sciences bereit erklärt, dem Vorstand von Neurotech gemeinsam ...

Netzwerk-Profile

Facebook: Ph.D. Lutz Giebel Profiles | Facebook

Lutz Giebel - KANDO

kando.tech

Lutz Giebel. Career. SV Life Sciences Advisers Inc · Fund management. Position: Managing Partner (Foster City) (current). edit · delete · Add a position.

Interessen

(1 - 4 von 5

–alle anzeigen

)

SV Life Sciences Raises Over US $523 Million for Fifth Fund, SV Life...

www.prnewswire.com

Bingham, Lutz Giebel, Eugene Hill, David Milne, and Michael ...

Lutz Giebel - $2,500 in Political Contributions for 2014

www.campaignmoney.com

Lutz Giebel - $2,500 in Political Contributions for 2014, Campaign Finance, Money, American politics, American political campaign contributions, presidential...

PanOptica Raises $30 Million in Series A Financing and Licenses Lead...

www.prnewswire.com

PanOptica Raises $30 Million in Series A Financing and Licenses Lead Compound for Development as Topical Treatment of AMD

AlloCure Names Robert M. Brenner, M.D. Chief Executive Officer

www.advfn.com

AlloCure Inc. AlloCure Names Robert M. Brenner, M.D. Chief Executive Officer

Firmen-Mitarbeiter

Team - Bridge Medicines | Accelerating the Path to the Patientbridgemedicines.com › team

bridgemedicines.com

Lutz Giebel is a Biotech Entrepreneur based in San Francisco Bay Area. He is currently co-founder and Chairman of Relinia Inc. Previously Lutz was co-founder ...

Private Homepages

Recent Edits for Lutz Giebel on CrunchBase

giebel3.rssing.com

Lutz Giebel revision 1 created on CrunchBase · Contact us about this article.

Lutz Giebel - Email, Phone - Chief Information Officer, ViaCyte

www.adapt.io

Lutz Giebel's email address , contact phone/mobile number +1******08. Working in ViaCyte as Chief Information Officer in California, United...

Bücher

(1 - 4 von 6

–alle anzeigen

)

The New York Times

archive.nytimes.com

Source: National Institutes of Health; Dr. Diane Krause, Yale; Dr. Lutz Giebel, CyThera Inc; Jones Institute for Reproductive Medicine. A human embryonic stem ...

Genomtechnologie und Stammzellforschung - ein verantwortbares Risiko...

books.google.de

Der Firmenchef Lutz GIEBEL, ein deutscher Wissenschaftler mit einem Vordiplom der Universität Bonn, als Katholik vom Cusanuswerk durch Stipendium ...

Medical Science and Bioethics: Attack of the Clones? : Hearing Before...

books.google.de

Quality control presents another hurdle, said Lutz Giebel, CEO of CyThera, a cell therapy company in San Diego. The Food and Drug Administration is set up to ...

Genomtechnologie und Stammzellforschung - ein ...

books.google.ca

Januar gewonnen. Der Firmenchef Lutz GIEBEL, ein deutscher Wissenschaftler mit einem Vordiplom der Universität Bonn, als Katholik vom Cusanuswerk ...

Dokumente zum Namen

(1 - 4 von 6

–alle anzeigen

)

Cell magazine stem cell biotech (feb 2008)

de.slideshare.net

Leading Edge Analysis Stem Cell Biotech: Seeking a Piece of the Action Venture capital groups and big pharma have largely held back from investing in biotech c…

SUMMIT KICK OFF WITH OPHTHALMOLOGY INNOVATION CYCLE & FINANCING UPDATE

www.slideshare.net

Presentation from OIS@ASCRS William J. Link, PhD, Managing Director – Versant Ventures

S (02) - Susan S. Taylor Laboratory

www.susantaylorlab.ucsd.edu

Ross, Lutz Giebel,. Dennis Pantazatos and Jack Kim for their considerable.

[PDF] Annual Report Full Donor List FY Free Download PDF

nanopdf.com

Download Annual Report Full Donor List FY

Veröffentlichungen allgemein

▷ Neurotech(TM) Inc. schliesst private Finanzierungsrunde ...

www.presseportal.de

... J. Link von Versant Ventures und Dr. Lutz Giebel von SV Life Sciences bereit erklärt, dem Vorstand von Neurotech gemeinsam mit Dr. med.

Artikel & Meinungen

Stem cells—a hard sell to investors | Nature Biotechnology

www.nature.com

A lack of proven commercial success and a surfeit of ethical, legal and political problems make stem cell companies a difficult pitch to venture capitalists.